Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-02

Clinical Trial Update: Intra-articular Administration of 3.0g Tranexamic Acid Has no Effect on Reducing Intra-articular Hemarthrosis and Postoperative Pain After Primary Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial found that intra-articular administration of 3.0 g tranexamic acid did not reduce intra-articular hemarthrosis or postoperative pain …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Korea University Guro Hospital | Conditions: Anterior Cruciate Ligament Rupture | Phase 4 | Status: UNKNOWN